Stefan Tomiuk

Title: The Innovative Contributions of Stefan Tomiuk

Introduction

Stefan Tomiuk is a notable inventor based in Cologne, Germany. He has made significant strides in the field of cancer therapy through his innovative work on chimeric antigen receptors. His contributions are vital in the ongoing battle against cancer, showcasing the potential of targeted therapies.

Latest Patents

Stefan Tomiuk holds a patent for a chimeric antigen receptor specific for tumor cells. This invention is directed towards a ligand-like chimeric antigen receptor (CAR), which includes an antigen binding domain specific for various antigens such as CLA, CD142, CD73, CD49c, CD66c, CD104, CD318, and TSPAN8. The patent emphasizes the use of cell populations expressing these CARs for effective cancer therapy. He has 1 patent to his name.

Career Highlights

Stefan Tomiuk is currently associated with Miltenyi Biotec B.V. & Co. KG, a company renowned for its advancements in biotechnology. His work at Miltenyi Biotec has allowed him to collaborate with other talented professionals in the field, further enhancing the impact of his inventions.

Collaborations

Some of his notable coworkers include Dominik Eckardt and Andreas Bosio. Their collective efforts contribute to the innovative environment at Miltenyi Biotec, fostering advancements in cancer treatment technologies.

Conclusion

Stefan Tomiuk's work exemplifies the importance of innovation in the medical field, particularly in cancer therapy. His patent on chimeric antigen receptors represents a significant step forward in targeted cancer treatments. The collaboration with his colleagues further amplifies the potential for future breakthroughs in this critical area of research.